Drugs / lyophilised plasma
last change Oct 2025 re-read 2 minutes ago

lyophilised plasma

Developed for
blood coagulation disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04431999 Comparator Dec 2021 → Oct 2025 blood coagulation disease Central Directorate of the Army Health Service Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as lyophilised plasma “Severe trauma patients with a life threatening bleeding will be managed with 3 packed red blood cells (PRBCs), 3 lyophilised plasma units and 1 dose of platelets for the 1st.” NCT04431999